A Randomized, Double-Blind, Placebo-Controlled, Multicentre Trial of the Effects of a Shrimp Protein Hydrolysate on Blood Pressure

Table 2

Baseline measurements for the placebo and RPC groups in the ITT population (n=144).

Variable	Placebo (n = 72)	RPC (n = 72)	p-value
SBP (mmHg)
Mean ± SD	147.3 ± 8.3	144.4 ± 6.5	0.019
Median (Min – Max)
DBP (mmHg)
Mean ± SD	88.1 ± 8.3	86.9 ± 6.7	0.329
Median (Min – Max)
Heart Rate (BPM)
Mean ± SD	71.3 ± 8.3	73.4 ± 8.7	0.139
Median (Min – Max)
Height (cm)
Mean ± SD	171.8 ± 9.7	171.0 ± 9.6	0.593
Median (Min – Max)
Weight (kg)
Mean ± SD	81.2 ± 13.4	81.2 ± 11.9	0.999
Median (Min – Max)
BMI (kg/m^2)
Mean ± SD	27.4 ± 3.1	27.8 ± 3.3	0.507
Median (Min – Max)

BMI: body mass index; BPM: beats per minute; cm: centimeters; DBP: diastolic blood pressure; kg: kilograms; kg/m²: kilogram per square meter; Max: maximum; Min: minimum; mmHg: millimeter of mercury; n: number; RPC: Refined Peptide Concentrate; SBP: systolic blood pressure; SD: standard deviation
Between-group comparisons were made using the Independent Student t-test. p≤0.05 was considered statistically significant.